Company intelligence / Profile preview

Darnatein

Yeonsu-gu, Incheon, Republic of Koreadarnatein.com ↗
Ownership
Private
Development stage
Other
01

Overview

Darnatein is a South Korean biotechnology company focused on developing next-generation regenerative biologics for musculoskeletal and tissue repair. As a subsidiary of OSR Holdings, the company utilizes its proprietary Design-Augmented (DA) Biologics platform, which integrates synthetic biology and AI-enhanced protein engineering to create super-agonists that restore signaling balance in the body. Its lead candidate, DRT-101, is a chimeric BMP-7/Activin protein being developed as a disease-modifying osteoarthritis drug (DMOAD). The company's pipeline also includes DRT-102, a BMP-2 super-agonist currently in clinical development for spinal fusion applications.

Therapeutic areas
RheumatologyOther
Modalities
Recombinant proteinRecombinant fusion proteinBiologic
Industry
Biotech
02

Drug pipeline

3 assets

DRT102-sp

Preclinical

2 more assets in the full pipeline.

03

Partnerships

BioToxTechUniversity of California, San Diego

Beyond the preview

Go deeper on Darnatein.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Darnatein.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call